“The availability of oncology drugs needs to improve, as only 57% of those approved in Europe are available”
The director of Farmaindustria’s Access department analyses the challenges in the access of these patients to pharmaceutical innovation at a conference of the Spanish Society of Medical Oncology (SEOM) Source: farmaindustria.es “One in four of the medicines authorised by the European Medicines Agency in recent years has an indication in oncology and in Spain only […]
Clinical trials, hope for today’s patients and new medicines for tomorrow’s patients
International Clinical Trials Day commemorates the importance of clinical trials every 20 May Clinical trials advance medicine and address unmet medical needs Source: farmaindustria.es In the 18th century, sailors died of scurvy during long voyages by ship. In search of a solution, Scottish physician James Lind tested different treatments in 1747 in what is considered […]
“The increase in international competitiveness and digitalisation will require more investment to ensure that Spain remains at the forefront of biomedical R&D”
The Deputy Director General of Farmaindustria, Javier Urzay, recalls that this is a key moment to define the country’s strategy in research to face the new challenges of the NHS The registration period for the 16th Annual Conference of Biomedical Research Technology Platforms, to be held in Madrid on 23 May, is now open Source: […]
“Bringing clinical trials closer to the patient’s home is a challenge in which the public and private sectors must go hand in hand”
This measure allows for greater participation and the inclusion of a more diverse population, which improves the scientific quality of the studies, as highlighted by Farmaindustria’s Associate Director of Clinical and Translational Research, Amelia Martín Uranga at an IESE Healthcare conference in Barcelona Source: farmaindustria.es The healthcare crisis triggered by the Covid-19 pandemic highlighted the […]
Farmaindustria assures that the revision of the European pharmaceutical legislation “puts the future of the industry at risk”
In the opinion of the employers’ association, it “represents yet another barrier to patient access to innovative treatments” Source: espaciosanitario.com Following the proposed revision of the European pharmaceutical legislation presented the day before by the European Commission, Farmaindustria has indicated, this Thursday, April 27, that this “puts the future of the industry at risk and […]
“It’s time for Europe to make up for lost ground in pharmaceutical innovation”
Farmaindustria brings together in Spain the main European National Associations representing the innovative pharmaceutical industry and the European Federation of the Pharmaceutical Industry together with the Spanish Medicines Agency to discuss how regulation can boost pharmaceutical innovation in the EU The Director General of Farmaindustria, Juan Yermo, highlights the opportunity opened up by the Spanish […]
Fifteen organisations sign up to the Code on Data Protection in Clinical Trials in its first year
Farmaindustria states that it is “the first sectoral code approved by the AEPD and a reference at European level” Source: espaciosanitario.com Farmaindustria has announced that a total of 15 companies, centres and research groups adhered to the Code of data protection in clinical trials in its first year, which is “the first sectoral code approved […]
Spain authorised more than 900 clinical trials with medicines in 2022, according to the Spanish Clinical Trials Register (REEC). These figures exceed those recorded in the years prior to the pandemic
Source: elperiodico.com Multiple sclerosis is an autoimmune disease of the central nervous system that affects the brain and spinal cord. It is caused by damage to the myelin sheath, the protective covering that surrounds nerve cells. When the sheath is damaged, nerve impulses slow down or stop. Among the most common symptoms of the disease […]
Paediatric clinical trials to grow by 24% by 2022, with special focus on cancer and nervous system diseases
Data from the Spanish Clinical Trials Register reveal the commitment of the pharmaceutical industry, which finances 88% of trials with paediatric patients. Incentives for innovation are fundamental in this field, along with that of rare diseases, so the new European regulation is a great opportunity to encourage even more research and investment that can benefit […]
Promoting R&D, equity, access and measurement of health outcomes, priorities for the pharmaceutical industry in the fight against cancer
Oncology is one of the key issues on the health agenda that Spain will take to the Presidency of the Council of the European Union in the second half of 2023 At a workshop organised by Farmaindustria and the CDTI, member companies learn about the development of the ‘Cancer Mission’, a pillar of the Horizon […]
ES
EN